The Impact of Local Intervention Combined with Targeted Therapy on Metastatic Renal Cell Carcinoma

Abstract

Complete resection of metastatic sites for MRCC patients, combined with targeted therapy, could provide better overall survival rates than targeted therapy alone. Poor MSKCC risk is still correlated to a poor outcome in the current targeted therapy era.